| Dr Steven E Knaus, MD | |
|
200 Theda Clark Medical Plz, Suite 380, Neenah, WI 54956-2721 | |
| (920) 727-9650 | |
| (920) 727-0430 |
| Full Name | Dr Steven E Knaus |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 34 Years |
| Location | 200 Theda Clark Medical Plz, Neenah, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457332215 | NPI | - | NPPES |
| 31910000 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 32321 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare At Home | Appleton, WI | Home health agency |
| Thedacare At Home | Appleton, WI | Hospice |
| Affinity Visiting Nurses | Neenah, WI | Hospice |
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Thedacare Regional Medical Center - Appleton Inc | Appleton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thedacare Incorporated | 1759294887 | 493 |
News Archive
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing, and commercializing innovative pain treatments, today announced that researchers will be presenting scientific data on SPRIX (ketorolac tromethamine) Nasal Spray, Egalet-001, an abuse-deterrent, extended-release, oral morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone product in development, at PainWeek 2015 to be held September 8 to 12 in Las Vegas, Nevada.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.
In a recent study, researchers from the U.S. examined the vaccine effectiveness against SARS-CoV-2 infections in Puerto Rico.
Diplomat, the country's largest independent specialty pharmacy, announced today it is one of five specialty pharmacies selected as a provider of IMBRUVICA (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration for the treatment of Mantle Cell Lymphoma.
› Verified 6 days ago
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing, and commercializing innovative pain treatments, today announced that researchers will be presenting scientific data on SPRIX (ketorolac tromethamine) Nasal Spray, Egalet-001, an abuse-deterrent, extended-release, oral morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone product in development, at PainWeek 2015 to be held September 8 to 12 in Las Vegas, Nevada.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.
In a recent study, researchers from the U.S. examined the vaccine effectiveness against SARS-CoV-2 infections in Puerto Rico.
Diplomat, the country's largest independent specialty pharmacy, announced today it is one of five specialty pharmacies selected as a provider of IMBRUVICA (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration for the treatment of Mantle Cell Lymphoma.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven E Knaus, MD Po Box 8003, Appleton, WI 54912-8003 Ph: (920) 996-3200 | Dr Steven E Knaus, MD 200 Theda Clark Medical Plz, Suite 380, Neenah, WI 54956-2721 Ph: (920) 727-9650 |
News Archive
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on discovering, developing, and commercializing innovative pain treatments, today announced that researchers will be presenting scientific data on SPRIX (ketorolac tromethamine) Nasal Spray, Egalet-001, an abuse-deterrent, extended-release, oral morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone product in development, at PainWeek 2015 to be held September 8 to 12 in Las Vegas, Nevada.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has achieved its enrollment target for TIVO-1, its global Phase 3 clinical trial for its oral, triple VEGF receptor inhibitor, tivozanib, in patients with advanced renal cell carcinoma. In February of this year, AVEO initiated enrollment in TIVO-1, and has successfully reached the target enrollment of 500 patients.
In a recent study, researchers from the U.S. examined the vaccine effectiveness against SARS-CoV-2 infections in Puerto Rico.
Diplomat, the country's largest independent specialty pharmacy, announced today it is one of five specialty pharmacies selected as a provider of IMBRUVICA (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration for the treatment of Mantle Cell Lymphoma.
› Verified 6 days ago
Kelsey Kienert, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Main St, Neenah, WI 54956 Phone: 920-720-1463 | |
Dr. Benjamin J Duffy, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Theda Clark Medical Plz Ste 420, Neenah, WI 54956 Phone: 920-720-7211 | |
William L Nelson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Main St, Neenah, WI 54956 Phone: 920-727-4220 | |
Dr. Barbara L Lauderdale, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 804 E Forest Ave, Neenah, WI 54956 Phone: 920-722-6692 | |
Taylor B Doberstein, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Theda Clark Medical Plz Ste 240, Neenah, WI 54956 Phone: 920-831-5050 Fax: 920-727-4511 | |
James R Burns, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Main St, Neenah, WI 54956 Phone: 920-727-4220 | |
Kim R Riess-sagers, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 N Commercial St, Suite 200, Neenah, WI 54956 Phone: 920-886-0818 Fax: 920-886-0773 |